利非西呱
1-benzyl-3-(5-hydroxymethyl-furan-2-yl)indazole;2-Furanmethanol,5-[1-(phenylmethyl)-1H-indazol-3-yl]-;lificiguat;YC 1;YC-1;1-Benzyl-3-(5-hydroxymethyl-2-furyl)-1H-indazole;1-benzyl-3-(5'-hydroxymethyl-2'-furyl)indazole;2-Furanmethanol,5-[1-(phenylmethyl)-1H-indazol-3-yl];3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole;5-[1-(PHENYLMETHYL)-1H-INDAZOL-3-YL]-2-FURANMETHANOL;3-(5′-Hydroxymethyl-2′-furyl)-1-benzyl indazole;1-Benzyl-3-(5-hydroxymethylfur-2-yl)indazole;YC 1 (pharmaceutical);Nsc728165;Lificiguat(YC-1);(5-(1-Benzyl-1H-indazol-3-yl)furan-2-yl)Methanol;3-(5-Hydroxymethyl-2-Furyl)-1-Benzylindazole;[5-(1-benzyl-1h-indazol-3-yl)-2-furyl]methanol;515CC1WPTE;OQQVFCKUDYMWGV-UHFFFAOYSA-N;C19H16N2O2;3-(5'-Hydroxymethyl-2'-furyl)-1-benzyl indazole;1-Benzyl-3-(5-hydroxymethyl-2-furyl)indazole;[5-(1-benzylindazol-3-yl)furan-2-yl]methanol;[5-(1-benzyl-1H-indazol-3-yl)furan-2-yl]methanol;5-[1-(Phenylmethyl)-1H-indazo;3-(5/'-hydroxymethyl-2/'-furyl)-1-benzylindazole;YC1;[5-[1-(phenylmethyl)indazo;LIFICIGUAT;YC 1 (pharMaceutical);3-(5'-HYDROXYMETHYL-2'-FURYL)-1-BENZYLINDAZOLE;Lificiguat;NCGC00016103-05;170632-47-0;CHEMBL333985;NCGC00261915-01;AKOS022180370;MLS002172480;CS-3363;LP01230;KBio2_005463;NSC-756879;CCG-205304;HMS3649M04;Lopac0_001230;SR-01000076202;Tox21_501230;KBio2_002895;NCGC00094472-01;Q27089256;KBio3_000653;BRD-K60476892-001-11-2;3-(5'-hydroxymethyl-2'furyl)-1-benzyl-indazole;5-a[1-a?phenylmethyl)-a?H-aindazol-a?-ayl]-a?-afuranmethanol;NCGC00016103-07;HMS1990A09;BSPBio_000987;2-Furanmethanol, 5-[1-(phenylmethyl)-1H-indazol-3-yl]-;HMS3403A09;BRD-K60476892-001-02-1;[5-(1-Benzyl-1H-indazol-3-yl)-furan-2-yl]-methanol;HMS3263F22;3-(5-hydroxymethyl-2-furyl)-1-benzylindazole;SCHEMBL187837;NSC728165;154453-18-6;NCGC00016103-17;VGA63247;(5-(1-benzyl-1H-indazol-3-yl)furan-2-yl)methanol;SMR000857214;5-[1-(Phenylmethyl)-1H-indazol-3-yl]-2-furanmethanol;HMS3373B12;KBioSS_000327;CHEBI:93060;KBio2_000327;DTXSID70165635;NCGC00016103-02;NCGC00016103-04;MLS006012048;CHEBI:142430;IDI1_002079;HMS2235B17;MLS001333258;LIFICIGUAT [WHO-DD];GTPL5291;A907557;AS-55797;HB3521;NCGC00094472-04;NCGC00016103-01;UNII-515CC1WPTE;EU-0101230;QTL1_000091;NCGC00016103-03;YC-1; Lificiguat;KBio3_000654;1-(1-benzyl-3-(5''-hydroxymethyl-2''-furyl)-indazole;YC-1(Lificiguat);NSC 728165;HMS1792A09;Lopac-Y-102;YC 1 compound;YC-1, powder;HMS1362A09;NSC756879;MLS001333257;NSC-728165;AC-29036;NCGC00094472-03;yc-1;NCGC00094472-02;KSC-412-005-;HY-14927;FT-0757306;SR-01000076202-7;Bio2_000804;EX-A2409;Y-102;KBioGR_000327;3-(5'-Hydroxymethyl-2'-furyl)-1-benzylindazole;SDCCGSBI-0051197.P002;BDBM50095469;Bio2_000324;MFCD06407798;[5-[1-(phenylmethyl)indazol-3-yl]furan-2-yl]methanol;KUC114162N;SR-01000076202-1;J-010636;YC-1 compound;BCP09072;lificiguatum;NCGC00016103-06;1-Benzyl-3-(5'-hydroxymethyl-2-furyl)indazole;Lificiguat [INN]